Cargando…

Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin

The Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study (FLAGS) and the Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial (DIGEST) have shown that patients with advanced gastric cancer treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeuchi, Madoka, Ajani, Jaffer A., Fang, Xuemin, Pfeiffer, Per, Takeuchi, Masahiro, van Laarhoven, Hanneke W. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627221/ https://www.ncbi.nlm.nih.gov/pubmed/31234436 http://dx.doi.org/10.3390/cancers11060871

Ejemplares similares

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

Recent advances in the management of gastric adenocarcinoma patients
por: Rogers, Jane E, et al.
Publicado: (2023)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Review of docetaxel in the treatment of gastric cancer
por: Tetzlaff, Eric D, et al.
Publicado: (2008)

Targeted literature review of the global burden of gastric cancer
por: Casamayor, Montserrat, et al.
Publicado: (2018)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

A Highly Advanced Gastric Cancer Maintaining a Clinical Complete Response after Chemoradiotherapy Comprising S-1 and Cisplatin
por: Yura, Masahiro, et al.
Publicado: (2018)

Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
por: Derks, Sarah, et al.
Publicado: (2022)

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
por: Wakai, Eri, et al.
Publicado: (2022)

Enrichment of CLDN18‐ARHGAP fusion gene in gastric cancers in young adults
por: Nakayama, Izuma, et al.
Publicado: (2019)

Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
por: Lim, Do Hyoung, et al.
Publicado: (2010)

The Number of Positive Tumor Markers (NPTM) Achieves Higher Value in the Prognosis Prediction of Gastric Cancer
por: Li, Limin, et al.
Publicado: (2022)

Case of early-stage gastric cancer identified in the gastric mucosa with lanthanum phosphate deposition
por: Takatsuna, Masafumi, et al.
Publicado: (2019)

Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study
por: Castillo‐Mancilla, Jose R, et al.
Publicado: (2019)

Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
por: Rogers, Jane E., et al.
Publicado: (2023)

Evolution of gastric surgery techniques and outcomes
por: Shiozaki, Hironori, et al.
Publicado: (2016)

Medical management of gastric cancer: a 2017 update
por: Charalampakis, Nikolaos, et al.
Publicado: (2017)

JGH Open ‐ ACHIEVING HIGHER STANDARDS
por: Goh, Khean‐Lee
Publicado: (2021)

An Integrated In Silico and In Vivo Approach to Identify Protective Effects of Palonosetron in Cisplatin-Induced Nephrotoxicity
por: Wakai, Eri, et al.
Publicado: (2020)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
por: Fuchs, Charles S, et al.
Publicado: (2016)

Inflammatory cytokine‐enriched microenvironment plays key roles in the development of breast cancers
por: Takeuchi, Yasuto, et al.
Publicado: (2023)

Treatment of Gastric Adenocarcinoma May Differ Among Hospital Types in the United States, a Report from the National Cancer Data Base
por: Reid-Lombardo, Kaye M., et al.
Publicado: (2007)

Asymptotic efficiency of statistical estimators concepts and higher order asymptotic efficiency
por: Akahira, Masafumi, et al.
Publicado: (1981)

Minimum values for midluteal plasma progesterone and estradiol concentrations in patients who achieved pregnancy with timed intercourse or intrauterine insemination without a human menopausal gonadotropin
por: Takaya, Yukiko, et al.
Publicado: (2018)

Can You Establish the Cause of This Patient's Shortness of Breath?
por: Trail, Allison, et al.
Publicado: (2023)

Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses
por: Tanaka, Yoshiya, et al.
Publicado: (2023)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)

SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer
por: van den Boorn, Héctor G., et al.
Publicado: (2019)

circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition
por: Liang, Qianping, et al.
Publicado: (2023)

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance
por: Harada, Kazuto, et al.
Publicado: (2018)

Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-
por: Matsuda, Satoru, et al.
Publicado: (2014)

Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
por: Naganuma, Makoto, et al.
Publicado: (2019)

The perceptions and experiences of women who achieved and did not achieve a waterbirth
por: Lewis, Lucy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_le6jomlq3dovic0008tbt7624f